145 related articles for article (PubMed ID: 22521316)
1. Defective PAX4 R192H transcriptional repressor activities associated with maturity onset diabetes of the young and early onset-age of type 2 diabetes.
Kooptiwut S; Plengvidhya N; Chukijrungroat T; Sujjitjoon J; Semprasert N; Furuta H; Yenchitsomanus PT
J Diabetes Complications; 2012; 26(4):343-7. PubMed ID: 22521316
[TBL] [Abstract][Full Text] [Related]
2. PAX4 R192H and P321H polymorphisms in type 2 diabetes and their functional defects.
Sujjitjoon J; Kooptiwut S; Chongjaroen N; Semprasert N; Hanchang W; Chanprasert K; Tangjittipokin W; Yenchitsomanus PT; Plengvidhya N
J Hum Genet; 2016 Nov; 61(11):943-949. PubMed ID: 27334367
[TBL] [Abstract][Full Text] [Related]
3. Aberrant mRNA splicing of paired box 4 (PAX4) IVS7-1G>A mutation causing maturity-onset diabetes of the young, type 9.
Sujjitjoon J; Kooptiwut S; Chongjaroen N; Tangjittipokin W; Plengvidhya N; Yenchitsomanus PT
Acta Diabetol; 2016 Apr; 53(2):205-16. PubMed ID: 25951767
[TBL] [Abstract][Full Text] [Related]
4. PAX4 R192H is associated with younger onset of Type 2 diabetes in East Asians in Singapore.
Ang SF; Tan CSH; Wang L; Dorajoo R; Fong JCW; Kon WYC; Lian JX; Ang K; Rahim JB; Jeevith B; Lee SBM; Tang WE; Subramanium T; Sum CF; Liu JJ; Lim SC
J Diabetes Complications; 2019 Jan; 33(1):53-58. PubMed ID: 30528630
[TBL] [Abstract][Full Text] [Related]
5. PAX4 mutations in Thais with maturity onset diabetes of the young.
Plengvidhya N; Kooptiwut S; Songtawee N; Doi A; Furuta H; Nishi M; Nanjo K; Tantibhedhyangkul W; Boonyasrisawat W; Yenchitsomanus PT; Doria A; Banchuin N
J Clin Endocrinol Metab; 2007 Jul; 92(7):2821-6. PubMed ID: 17426099
[TBL] [Abstract][Full Text] [Related]
6. Ghrelin is a novel target of Pax4 in endocrine progenitors of the pancreas and duodenum.
Wang Q; Elghazi L; Martin S; Martins I; Srinivasan RS; Geng X; Sleeman M; Collombat P; Houghton J; Sosa-Pineda B
Dev Dyn; 2008 Jan; 237(1):51-61. PubMed ID: 18058910
[TBL] [Abstract][Full Text] [Related]
7. A novel PAX4 mutation in a Japanese patient with maturity-onset diabetes of the young.
Jo W; Endo M; Ishizu K; Nakamura A; Tajima T
Tohoku J Exp Med; 2011 Feb; 223(2):113-8. PubMed ID: 21263211
[TBL] [Abstract][Full Text] [Related]
8. No evidence of linkage or diabetes-associated mutations in the transcription factors BETA2/NEUROD1 and PAX4 in Type II diabetes in France.
Dupont S; Vionnet N; Chèvre JC; Gallina S; Dina C; Seino Y; Yamada Y; Froguel P
Diabetologia; 1999 Apr; 42(4):480-4. PubMed ID: 10230653
[TBL] [Abstract][Full Text] [Related]
9. Paired-homeodomain transcription factor PAX4 acts as a transcriptional repressor in early pancreatic development.
Smith SB; Ee HC; Conners JR; German MS
Mol Cell Biol; 1999 Dec; 19(12):8272-80. PubMed ID: 10567552
[TBL] [Abstract][Full Text] [Related]
10. Pax4 represses pancreatic glucagon gene expression.
Petersen HV; Jørgensen MC; Andersen FG; Jensen J; F-Nielsen T; Jørgensen R; Madsen OD; Serup P
Mol Cell Biol Res Commun; 2000 Apr; 3(4):249-54. PubMed ID: 10891400
[TBL] [Abstract][Full Text] [Related]
11. Ethnic-Specific Type 2 Diabetes Risk Factor PAX4 R192H Is Associated with Attention-Specific Cognitive Impairment in Chinese with Type 2 Diabetes.
Ang SF; Low S; Ng TP; Tan CSH; Ang K; Lim Z; Tang WE; Subramaniam T; Sum CF; Lim SC
J Alzheimers Dis; 2022; 88(1):241-249. PubMed ID: 35570489
[TBL] [Abstract][Full Text] [Related]
12. PAX4 gene variations predispose to ketosis-prone diabetes.
Mauvais-Jarvis F; Smith SB; Le May C; Leal SM; Gautier JF; Molokhia M; Riveline JP; Rajan AS; Kevorkian JP; Zhang S; Vexiau P; German MS; Vaisse C
Hum Mol Genet; 2004 Dec; 13(24):3151-9. PubMed ID: 15509590
[TBL] [Abstract][Full Text] [Related]
13. The diabetes-linked transcription factor Pax4 is expressed in human pancreatic islets and is activated by mitogens and GLP-1.
Brun T; Hu He KH; Lupi R; Boehm B; Wojtusciszyn A; Sauter N; Donath M; Marchetti P; Maedler K; Gauthier BR
Hum Mol Genet; 2008 Feb; 17(4):478-89. PubMed ID: 17989064
[TBL] [Abstract][Full Text] [Related]
14. The simultaneous loss of Arx and Pax4 genes promotes a somatostatin-producing cell fate specification at the expense of the alpha- and beta-cell lineages in the mouse endocrine pancreas.
Collombat P; Hecksher-Sørensen J; Broccoli V; Krull J; Ponte I; Mundiger T; Smith J; Gruss P; Serup P; Mansouri A
Development; 2005 Jul; 132(13):2969-80. PubMed ID: 15930104
[TBL] [Abstract][Full Text] [Related]
15. Lack of PAX4 mutations in 53 Czech MODYX families.
Dusatkova P; Vesela K; Pruhova S; Lebl J; Cinek O
Diabet Med; 2010 Dec; 27(12):1459-60. PubMed ID: 21059099
[No Abstract] [Full Text] [Related]
16. A common functional regulatory variant at a type 2 diabetes locus upregulates ARAP1 expression in the pancreatic beta cell.
Kulzer JR; Stitzel ML; Morken MA; Huyghe JR; Fuchsberger C; Kuusisto J; Laakso M; Boehnke M; Collins FS; Mohlke KL
Am J Hum Genet; 2014 Feb; 94(2):186-97. PubMed ID: 24439111
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Pax4 paired homeodomain gene by neuron-restrictive silencer factor.
Kemp DM; Lin JC; Habener JF
J Biol Chem; 2003 Sep; 278(37):35057-62. PubMed ID: 12829700
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of PAX4 reduces glucagon expression in differentiating hESCs.
Gage BK; Baker RK; Kieffer TJ
Islets; 2014; 6(2):e29236. PubMed ID: 25483960
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation and maturity onset diabetes of the young transcription factors control the human PAX4 promoter.
Smith SB; Watada H; Scheel DW; Mrejen C; German MS
J Biol Chem; 2000 Nov; 275(47):36910-9. PubMed ID: 10967107
[TBL] [Abstract][Full Text] [Related]
20. PAX4 loss of function increases diabetes risk by altering human pancreatic endocrine cell development.
Lau HH; Krentz NAJ; Abaitua F; Perez-Alcantara M; Chan JW; Ajeian J; Ghosh S; Lee Y; Yang J; Thaman S; Champon B; Sun H; Jha A; Hoon S; Tan NS; Gardner DS; Kao SL; Tai ES; Gloyn AL; Teo AKK
Nat Commun; 2023 Sep; 14(1):6119. PubMed ID: 37777536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
